Degradation of pharmaceuticals in UV (LP)/H₂O₂ reactors simulated by means of kinetic modeling and computational fluid dynamics (CFD). [electronic resource]

By:

Wols, B A

Contributor(s):

Harmsen, D J H
Wanders-Dijk, J
Beerendonk, E F
Hofman-Caris, C H M

Producer: 20151230Description: 11-24 p. digitalISSN:

1879-2448

Subject(s):

Hydrodynamics
Hydrogen Peroxide -- chemistry
Kinetics
Models, Theoretical
Pharmaceutical Preparations -- chemistry
Photolysis
Temperature
Ultraviolet Rays
Waste Disposal, Fluid -- methods
Water Pollutants, Chemical -- chemistry
Water Purification -- methods

Online resources:

Available from publisher's website

In: Water research vol. 75

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Browse results Close

Back to results

861 No effect on QT intervals of mipomersen, a 2'-O-methoxyethyl modified antisense oligonucleotide targeting ApoB-100 mRNA, in a phase I dose escalation placebo-controlled study, and confirmed by a thorough QT (tQT) study, in healthy subjects.
by Yu, Rosie Z
862 The assembly and secretion of ApoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins.
by Borén, J
863 Apolipoprotein synthesis in nonalcoholic steatohepatitis.
by Charlton, Michael
864 Comparison of intraperitoneal and posterior subcutaneous abdominal adipose tissue compartments as predictors of VLDL apolipoprotein B-100 kinetics in overweight/obese men.
by Chan, D C
865 Cellular metabolism of triglyceride-rich lipoproteins: role of heparan sulfate, lipoprotein lipase and lipoprotein receptors.
by Sehayek, E
866 Copper deficiency increases hepatic apolipoprotein B secretion and mRNA editing in rats.
by Reaves, S K
867 Metabolism of apolipoprotein B-100 in a kindred with familial hypobetalipoproteinemia without a truncated form of apoB.
by Latour, M A
868 Localization of apolipoprotein(a) and B-100 in various renal diseases.
by Sato, H
869 Oleate stimulates the formation of triglyceride-rich particles containing apoB100-apo(a) in long-term primary cultures of human hepatocytes.
by Edelstein, C
870 Melatonin inhibits oxidative modification of human low-density lipoprotein.
by Kelly, M R
871 Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
by Tremblay, André J
872 A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation.
by Lin, Xiaobo
873 Catalysis of covalent Lp(a) assembly: evidence for an extracellular enzyme activity that enhances disulfide bond formation.
by Becker, Lev
874 Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity.
by Fernández-Higuero, J A
875 Serum apolipoprotein B is associated with increased risk of metabolic syndrome among middle-aged and elderly Chinese: A cross-sectional and prospective cohort study.
by Du, Rui
876 Thrombin cleavage of apolipoprotein Bh of rabbit LDL: structural comparisons with human apolipoprotein B-100.
by Leroy, A
877 Butyrate stimulates the secretion of apolipoprotein A-I and apolipoprotein B-100 in Hep G2 cells by different mechanisms.
by Kaptein, A
878 Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100.
by Fong, L G
879 Determinants of kallikrein proteolysis of apolipoprotein B-100 in human blood plasma.
by Gustafson, A
880 Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.
by Barnhart, R L

Degradation of pharmaceuticals in UV (LP)/H₂O₂ reactors simulated by means of kinetic modeling and computational fluid dynamics (CFD).

APA

Wols B. A., Harmsen D. J. H., Wanders-Dijk J., Beerendonk E. F. & Hofman-Caris C. H. M. (20151230). Degradation of pharmaceuticals in UV (LP)/H₂O₂ reactors simulated by means of kinetic modeling and computational fluid dynamics (CFD). : Water research.

Chicago

Wols B A, Harmsen D J H, Wanders-Dijk J, Beerendonk E F and Hofman-Caris C H M. 20151230. Degradation of pharmaceuticals in UV (LP)/H₂O₂ reactors simulated by means of kinetic modeling and computational fluid dynamics (CFD). : Water research.

Harvard

Wols B. A., Harmsen D. J. H., Wanders-Dijk J., Beerendonk E. F. and Hofman-Caris C. H. M. (20151230). Degradation of pharmaceuticals in UV (LP)/H₂O₂ reactors simulated by means of kinetic modeling and computational fluid dynamics (CFD). : Water research.

MLA

Wols B A, Harmsen D J H, Wanders-Dijk J, Beerendonk E F and Hofman-Caris C H M. Degradation of pharmaceuticals in UV (LP)/H₂O₂ reactors simulated by means of kinetic modeling and computational fluid dynamics (CFD). : Water research. 20151230.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC